Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kinsley, B. T.
Right arrow Articles by Jacobson, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kinsley, B. T.
Right arrow Articles by Jacobson, A. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 22, Issue 7 1022-1028, Copyright © 1999 by American Diabetes Association


ARTICLES

Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes

BT Kinsley, K Weinger, M Bajaj, CJ Levy, DC Simonson, M Quigley, DJ Cox and AM Jacobson
Section of Diabetes and Metabolism, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

OBJECTIVE: To determine the effect of blood glucose awareness training (BGAT) on epinephrine and symptom responses to hypoglycemia in patients with type 1 diabetes enrolled in an intensive diabetes treatment (IDT) program. RESEARCH DESIGN AND METHODS: A total of 47 subjects with uncomplicated diabetes (duration 9 +/- 3 years: HbA1c 9.0 +/- 1.2%; reference range 4-6%) enrolled in a 4-month outpatient IDT program were randomized to classes in BGAT (n = 25) (BGAT group) or cholesterol awareness (n = 22) (control group). Subjects underwent stepped hypoglycemic clamp studies before and at completion of IDT. Plasma glucose was lowered from 6.7 mmol/l (baseline) to 4.4, 3.9, 3.3, 2.8, and 2.2 mmol/l over 190 min. Symptoms, counterregulatory hormones, and ability of the subject to estimate their glucose level were assessed at each plateau. At home, subjects used a handheld computer to first estimate and then measure and record blood glucose levels for 70 trials over a 4-week period immediately before IDT and again immediately following the educational intervention. RESULTS: HbA1c decreased in both BGAT group (9.1 +/- 1.4 to 7.9 +/- 1.1%; P < 0.001) and control group (9.0 +/- 1.1 to 7.8 +/- 0.8%; P < 0.001) (NS between groups). Frequency of hypoglycemia (< 3.9 mmol/l) increased in both groups, from 0.45 +/- 0.06 to 0.69 +/- 0.07 episodes per day (P < 0.001) in the BGAT group and from 0.50 +/- 0.08 to 0.68 +/- 0.06 episodes per day (P < 0.05) in the control group NS between groups). Epinephrine responses after IDT were greater in the BGAT group (repeated measure analysis of variance [ANOVA], F = 3.5, P < 0.05). A separate analysis of subjects n = 26) most at risk for hypoglycemia (HbA1c after IDT < 7.8% or an HbA1c improvement of > 2 percentage points) showed that frequency of hypoglycemia increased in both the groups: from 0.50 +/- 0.09 to 0.80 +/- 0.11 episodes per day (P < 0.01) in the BGAT group (n = 14) and from 0.43 +/- 0.11 to 0.75 +/- 0.07 episodes per day (P < 0.05) in the control group (n = 12) (NS between groups). However, the epinephrine response in control subjects decreased with IDT while the response in the BGAT subjects was preserved (repeated measure ANOVA, F = 4.4, P < 0.02). CONCLUSIONS: BGAT is a useful intervention to decrease blunting of counterregulatory responses associated with improved glycemic control and may modify the severity of hypoglycemia associated with improved glycemic control in type 1 diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
A. D.M. Stork, T. W. van Haeften, and T. F. Veneman
Diabetes and Driving: Desired data, research methods and their pitfalls, current knowledge, and future research
Diabetes Care, August 1, 2006; 29(8): 1942 - 1949.
[Full Text] [PDF]


Home page
J Pediatr PsycholHome page
M. M. Lane
Advancing the Science of Perceptual Accuracy in Pediatric Asthma and Diabetes
J. Pediatr. Psychol., April 1, 2006; 31(3): 233 - 245.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
D. J. Cox, L. Gonder-Frederick, L. Ritterband, K. Patel, H. Schachinger, G. Fehm-Wolfsdorf, N. Hermanns, F. Snoek, J. Zrebiec, W. Polonsky, et al.
Blood Glucose Awareness Training: What Is It, Where Is It, and Where Is It Going?
Diabetes Spectr, January 1, 2006; 19(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
Diabetes Spectr.Home page
N. van der Ven
Psychosocial Group Interventions in Diabetes Care
Diabetes Spectr, April 1, 2003; 16(2): 88 - 95.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. J. Cox, L. Gonder-Frederick, W. Polonsky, D. Schlundt, B. Kovatchev, and W. Clarke
Blood Glucose Awareness Training (BGAT-2): Long-term benefits
Diabetes Care, April 1, 2001; 24(4): 637 - 642.
[Abstract] [Full Text]


Home page
Diabetes Spectr.Home page
R. E. Glasgow, D. J. Toobert, and C. D. Gillette
Psychosocial Barriers to Diabetes Self-Management and Quality of Life
Diabetes Spectr, January 1, 2001; 14(1): 33 - 41.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.